Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study

Kensei Tobinai, Toshiki Uchida, Noriko Fukuhara, Tomoaki Nishikawa

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study'. Together they form a unique fingerprint.